Publication | Closed Access

Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion

Hematological MalignancyMedicineApoptosisImmunologyCancer Cell BiologyCell DeathChronic Myelogenous LeukemiaNf-κb InhibitionCell Death MechanismsCell BiologyCancer ResearchTumor BiologyMyeloid Neoplasia